{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:59:24Z","timestamp":1772762364716,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jpurol.2012.02.008","type":"journal-article","created":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T23:43:53Z","timestamp":1331595833000},"page":"336-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladder"],"prefix":"10.1016","volume":"8","author":[{"given":"Bimal","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"El-Tahtawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen Q.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Darekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandini","family":"Cossons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim J.","family":"Crook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Scholfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2012.02.008_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00148581-200709060-00005","article-title":"Pediatric overactive bladder syndrome: pathophysiology and management","volume":"9","author":"Franco","year":"2007","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jpurol.2012.02.008_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00467-008-0764-7","article-title":"Neurogenic bladder: etiology and assessment","volume":"23","author":"Bauer","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00467-007-0691-z","article-title":"The neurogenic bladder: medical treatment","volume":"23","author":"Verpoorten","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the international continence society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2012.02.008_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0090-4295(02)01793-4","article-title":"Special considerations of the overactive bladder in children","volume":"60","author":"Bauer","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2012.02.008_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-5347(06)00305-3","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: report from the standardisation committee of the international children's continence society","volume":"176","author":"Neveus","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00467-008-0780-7","article-title":"Treatment of the neurogenic bladder in spina bifida","volume":"23","author":"de Jong","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.juro.2007.05.076","article-title":"Overactive bladder in children. Part 2: management","volume":"178","author":"Franco","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpurol.2008.05.003","article-title":"Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity","volume":"4","author":"Reddy","year":"2008","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000102915","article-title":"Long-term efficacy of tolterodine and patient compliance in pediatric patients with neurogenic detrusor overactivity","volume":"79","author":"Christoph","year":"2007","journal-title":"Urol Int"},{"key":"10.1016\/j.jpurol.2012.02.008_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1464-410X.2009.09129.x","article-title":"Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: results of a multicentre observational cohort study","volume":"106","author":"Alloussi","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2012.02.008_bib12","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.juro.2010.03.124","article-title":"Prospective open label study of solifenacin for overactive bladder in children","volume":"184","author":"Bolduc","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/01.ju.0000152322.17542.63","article-title":"Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials","volume":"173","author":"Nijman","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib14","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/01.ju.0000176622.81796.89","article-title":"Use of tolterodine in children with neurogenic detrusor overactivity: relationship between dose and urodynamic response","volume":"174","author":"Ellsworth","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib15","series-title":"Toviaz (fesoterodine fumarate): full prescribing information","year":"2011"},{"key":"10.1016\/j.jpurol.2012.02.008_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2125.2011.03948.x","article-title":"Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers","volume":"72","author":"Malhotra","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00228-009-0748-y","article-title":"The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing","volume":"66","author":"Malhotra","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.5414\/CPP46556","article-title":"Pharmacokinetic profile of fesoterodine","volume":"46","author":"Malhotra","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"Suppl. 8","key":"10.1016\/j.jpurol.2012.02.008_bib19","first-page":"S37","article-title":"Overactive bladder in special patient populations","volume":"5","author":"Appell","year":"2003","journal-title":"Rev Urol"},{"key":"10.1016\/j.jpurol.2012.02.008_bib20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.eururo.2007.07.009","article-title":"Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder","volume":"52","author":"Chapple","year":"2007","journal-title":"Eur Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513112000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513112000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:37:21Z","timestamp":1761485841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513112000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1477513112000460"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2012.02.008","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladder","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2012.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}